BioIntelliSense Announces FDA Clearance of the BioButton® Multi-Patient Wearable and BioDashboard™
BioIntelliSense expands its portfolio of continuous monitoring solutions with the rechargeable and reusable FDA-cleared BioButton® Multi-Patient wearable and BioDashboard™ clinical intelligence system for scalable exception management and automated vital sign collection.
Recent News
Solving for Telemetry Overuse in Patient Monitoring with BioIntelliSense
Current challenges in patient monitoring Telemetry has become a standard tool in hospitals for monitoring patients who require continuous ECG monitoring, but evidence shows it’s widely overused. Up to 43%…
Earlier Detection, Better Outcomes: Houston Methodist ICU Transfer Results with BioButton
New research from Houston Methodist published in the Journal of Clinical Medicine reveals the life-saving potential of continuous patient monitoring at scale. Houston Methodist studied 1,120 high-risk patients undergoing transfer…
BioIntelliSense Announces Observational Study in Journal of Clinical Medicine
The large-scale study of nearly 12,000 hospitalized patients highlights continuous multiparameter vital sign monitoring resulted in significant positive impact on patient outcomes BioIntelliSense, a continuous health monitoring and clinical intelligence…
BioIntelliSense Partners with Hicuity Health
The new partnership integrates the BioIntelliSense medical-grade BioButton® wearable and BioDashboard™ clinical intelligence solution with Hicuity Health’s robust patient monitoring services to scale virtual care programs from in-hospital to home….
BioIntelliSense Announces FDA Clearance of the BioButton® Multi-Patient Wearable and BioDashboard™
BioIntelliSense, a continuous health monitoring and clinical intelligence company, announces FDA clearance of the rechargeable BioButton® Multi-Patient wearable and BioDashboard™ system to cost-effectively grow and scale hospital virtual care programs….
BioIntelliSense Announces Completion of Houston Methodist Inpatient Expansion of the BioButton
The BioIntelliSense FDA-cleared BioButton® multiparameter wearable is now monitoring tens of thousands of patients across more than 2,600 non-ICU beds across Houston Methodist as part of the leading healthcare system’s…